Peters Richard has filed 6 insider transactions across 1 company since June 2024.
Most recent transaction: a purchase of 123915 shares of Aprea Therapeutics, Inc. ($APRE) on March 31, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Aprea Therapeutics, Inc. | $APRE | Peters Richard | Director | P | Pre-Funded Warrant | 123915 | $0.81 | 123,915.0000 | 6,538,722 | 9999.99% | 1.90% |
| March 31, 2026 | Aprea Therapeutics, Inc. | $APRE | Peters Richard | Director | P | Common Warrant | 123915 | $0.00 | 123,915.0000 | 6,538,722 | 9999.99% | 1.90% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Peters Richard | Director | A | Common Stock | 1045 | $0.00 | 3,119.0000 | 5,993,866 | 50.39% | 0.02% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Peters Richard | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Peters Richard | Director | A | Common Stock | 1045 | $0.00 | 2,074.0000 | 4,198,326 | 101.55% | 0.02% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Peters Richard | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |